157 related articles for article (PubMed ID: 25734096)
1. Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study.
Einsiedel L; Cassar O; Goeman E; Spelman T; Au V; Hatami S; Joseph S; Gessain A
Open Forum Infect Dis; 2014 Mar; 1(1):ofu023. PubMed ID: 25734096
[TBL] [Abstract][Full Text] [Related]
2. Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians.
Einsiedel L; Pham H; Wilson K; Walley R; Turpin J; Bangham C; Gessain A; Woodman RJ
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006281. PubMed ID: 29529032
[TBL] [Abstract][Full Text] [Related]
3. Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study.
Einsiedel L; Pham H; Au V; Hatami S; Wilson K; Spelman T; Jersmann H
ERJ Open Res; 2019 Oct; 5(4):. PubMed ID: 31911928
[TBL] [Abstract][Full Text] [Related]
4. Higher HTLV-1c proviral loads are associated with blood stream infections in an Indigenous Australian population.
Einsiedel L; Cassar O; Spelman T; Joseph S; Gessain A
J Clin Virol; 2016 May; 78():93-8. PubMed ID: 27011343
[TBL] [Abstract][Full Text] [Related]
5. Higher human T-cell leukaemia virus type 1 (HTLV-1) proviral load is associated with end-stage kidney disease in Indigenous Australians: Results of a case-control study in central Australia.
Talukder MRR; Walley R; Pham H; Schinke S; Woodman R; Wilson K; Sajiv C; Einsiedel L
J Med Virol; 2019 Oct; 91(10):1866-1872. PubMed ID: 31254397
[TBL] [Abstract][Full Text] [Related]
6. Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population.
Einsiedel L; Fernandes L; Spelman T; Steinfort D; Gotuzzo E
Clin Infect Dis; 2012 Jan; 54(1):43-50. PubMed ID: 22095566
[TBL] [Abstract][Full Text] [Related]
7. Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population.
Einsiedel L; Spelman T; Goeman E; Cassar O; Arundell M; Gessain A
PLoS Negl Trop Dis; 2014; 8(1):e2643. PubMed ID: 24454973
[TBL] [Abstract][Full Text] [Related]
8. Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.
Einsiedel L; Woodman RJ; Flynn M; Wilson K; Cassar O; Gessain A
BMC Public Health; 2016 Aug; 16():787. PubMed ID: 27526923
[TBL] [Abstract][Full Text] [Related]
9. Multiplex Droplet Digital PCR Assay for Quantification of Human T-Cell Leukemia Virus Type 1 Subtype c DNA Proviral Load and T Cells from Blood and Respiratory Exudates Sampled in a Remote Setting.
Yurick D; Khoury G; Clemens B; Loh L; Pham H; Kedzierska K; Einsiedel L; Purcell D
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30518541
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary Disease Is Associated With Human T-Cell Leukemia Virus Type 1c Infection: A Cross-sectional Survey in Remote Aboriginal Communities.
Einsiedel L; Pham H; Talukder MRR; Liddle J; Taylor K; Wilson K; Jersmann H; Gessain A; Woodman R; Kaldor J
Clin Infect Dis; 2021 Oct; 73(7):e1498-e1506. PubMed ID: 32936911
[TBL] [Abstract][Full Text] [Related]
11. High Human T-Cell Leukemia Virus Type 1c Proviral Loads Are Associated With Diabetes and Chronic Kidney Disease: Results of a Cross-Sectional Community Survey in Central Australia.
Talukder MR; Woodman R; Pham H; Wilson K; Gessain A; Kaldor J; Einsiedel L
Clin Infect Dis; 2023 Feb; 76(3):e820-e826. PubMed ID: 35903021
[TBL] [Abstract][Full Text] [Related]
12. The Association between Diabetes and Human T-Cell Leukaemia Virus Type-1 (HTLV-1) with
Talukder MR; Pham H; Woodman R; Wilson K; Taylor K; Kaldor J; Einsiedel L
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206272
[TBL] [Abstract][Full Text] [Related]
13. A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia.
Cassar O; Charavay F; Touzain F; Jeannin P; Grangeon JP; Laumond S; Chungue E; Martin PM; Gessain A
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005278. PubMed ID: 28060812
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and clinical associations of HTLV-1 infection in a remote Indigenous community.
Einsiedel LJ; Pham H; Woodman RJ; Pepperill C; Taylor KA
Med J Aust; 2016 Oct; 205(7):305-9. PubMed ID: 27681971
[TBL] [Abstract][Full Text] [Related]
15. Turning a blind eye: HTLV-1-associated uveitis in Indigenous adults from Central Australia.
Chew R; Henderson T; Aujla J; Whist E; Einsiedel L
Int Ophthalmol; 2018 Oct; 38(5):2159-2162. PubMed ID: 28755019
[TBL] [Abstract][Full Text] [Related]
16. Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases.
Demontis MA; Hilburn S; Taylor GP
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):359-64. PubMed ID: 22894552
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for HTLV-1, acute kidney injury, and urinary tract infection among aboriginal adults with end stage kidney disease in central Australia.
Talukder MR; Clauss CS; Cherian S; Woodman R; Einsiedel L
J Med Virol; 2021 Nov; 93(11):6362-6370. PubMed ID: 34173977
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
19. Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes.
Ueno S; Umeki K; Takajo I; Nagatomo Y; Kusumoto N; Umekita K; Morishita K; Okayama A
Int J Cancer; 2012 May; 130(10):2318-26. PubMed ID: 21780105
[TBL] [Abstract][Full Text] [Related]
20. Droplet digital PCR for absolute quantification of proviral load of human T-cell lymphotropic virus (HTLV) types 1 and 2.
Thulin Hedberg S; Eriksson L; Demontis MA; Mölling P; Sundqvist M; Taylor G; Malm K; Andersson S
J Virol Methods; 2018 Oct; 260():70-74. PubMed ID: 30006102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
